Market Overview:
The global thromboelastography analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, technological advancements in thromboelastography analyzers, and rising demand for point-of-care testing. However, the high cost of thromboelastography analyzers may restrain the growth of this market to some extent. Based on type, the global thromboelastography analyzer market is segmented into single channel and double channel, four channels, and others. The single channel segment is expected to account for the largest share of the global thromboelastography analyzer market in 2018 owing to its low cost and easy availability. However, with technological advancements being made in this field on a regular basis, double channel devices are likely to gain traction over single channel devices during the forecast period from 2018to 2030.
Product Definition:
A thromboelastography analyzer is a medical device that is used to measure the blood clotting ability of a patient. This information can be used to help diagnose and treat various clotting disorders.
Single and Double Channel:
Single and double channel are the two types of Thromboelastography (TEG) analyzers available in the market. Single channel is a traditional device used for measuring high power thrombus in blood vessels whereas, double-channel TEG measures both single and background channels simultaneously. The major advantage associated with this technology is that it provides accurate results even if there are multiple thrombi present in the blood vessel.
Four Channels:
The four channels test is used to measure the degree of coagulation in patients with acute coronary syndrome (ACS) or myocardial infarction. It also helps in monitoring the response of anticoagulants and heparin to a thrombolytic drug. The test uses an automated analyzer which measures different components such as fibrinogen, D-dimer, platelet count and plasma viscosity.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2017. The primary factor contributing to this growth is an increase in the incidence of thromboembolism and pulmonary embolism. According to a study published by NCBI, out of 10 million cases annually, around 300,000 people develop venous thromboembolic disease which requires medical treatment and affects mostly geriatric population above 60 years. Rising awareness about these diseases coupled with rising incidences are driving the market for hospital applications.
Maternal and child health service application segment is expected to grow at fastest rate during forecast period owing to rise in M&C units globally due largely to increasing number of deliveries per year resulting into increased demand for anticoagulants worldwide especially across developing countries such as China India Brazil Indonesia etcetera resulting into increased sales for maternal & child health services over the forecast period globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and availability of reimbursement facilities for thromboelastography. The U.S., which is at the forefront, has a well-developed healthcare infrastructure and an increasing number of patients opting for technologically advanced products that are not only costlier but also offer better results than traditional ones.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare facilities due to increased government spending on this sector and rising awareness among people regarding available treatment options in emerging countries like China & India & Australia coupled with growing medical tourism industry in these regions will drive demand during the forecast period from 2018 To 2030 Thromboelastography analyzers have been approved by regulatory agencies such as FDA (Food and Drug Administration) in U.S.
Growth Factors:
- Increasing demand for thromboelastography analyzers in hospitals and clinics for accurate diagnosis of blood clotting disorders.
- Rising prevalence of thrombotic diseases such as deep vein thrombosis, pulmonary embolism, and myocardial infarction.
- Growing number of surgical procedures requiring use of thromboelastography analyzers for effective blood clot management during surgery.
- Technological advancements in the field of thromboelastography that are making these devices more efficient and user-friendly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thromboelastography Analyzer Sales Market Research Report
By Type
Single and Double Channel, Four Channels, Others
By Application
Hospital, Maternal and Child Health Service, Laboratory, Others
By Companies
Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Thromboelastography Analyzer Sales Market Report Segments:
The global Thromboelastography Analyzer Sales market is segmented on the basis of:
Types
Single and Double Channel, Four Channels, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Maternal and Child Health Service, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics
- Lepu Technology
- Biomart
- Medcaptain
- Ud-bio
- Chongqing Nanfang
- WITEYE
- Render
- Guizhou Jinjiu Biotech
- Chongqing Dingrun
- Zhejiang Shengyu
- Bio-zircon
- WerfenLife
- Framar Hemologix srl
- Sienco
Highlights of The Thromboelastography Analyzer Sales Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single and Double Channel
- Four Channels
- Others
- By Application:
- Hospital
- Maternal and Child Health Service
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thromboelastography Analyzer Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Thromboelastography Analyzer is a medical device used to measure the thrombus formation in blood vessels.
Some of the major players in the thromboelastography analyzer sales market are Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco.
The thromboelastography analyzer sales market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thromboelastography Analyzer Sales Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Thromboelastography Analyzer Sales Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Thromboelastography Analyzer Sales Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Thromboelastography Analyzer Sales Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Thromboelastography Analyzer Sales Market Size & Forecast, 2018-2028 4.5.1 Thromboelastography Analyzer Sales Market Size and Y-o-Y Growth 4.5.2 Thromboelastography Analyzer Sales Market Absolute $ Opportunity
Chapter 5 Global Thromboelastography Analyzer Sales Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thromboelastography Analyzer Sales Market Size Forecast by Type
5.2.1 Single and Double Channel
5.2.2 Four Channels
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thromboelastography Analyzer Sales Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thromboelastography Analyzer Sales Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Maternal and Child Health Service
6.2.3 Laboratory
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thromboelastography Analyzer Sales Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thromboelastography Analyzer Sales Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thromboelastography Analyzer Sales Analysis and Forecast
9.1 Introduction
9.2 North America Thromboelastography Analyzer Sales Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thromboelastography Analyzer Sales Market Size Forecast by Type
9.6.1 Single and Double Channel
9.6.2 Four Channels
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thromboelastography Analyzer Sales Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Maternal and Child Health Service
9.10.3 Laboratory
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thromboelastography Analyzer Sales Analysis and Forecast
10.1 Introduction
10.2 Europe Thromboelastography Analyzer Sales Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thromboelastography Analyzer Sales Market Size Forecast by Type
10.6.1 Single and Double Channel
10.6.2 Four Channels
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thromboelastography Analyzer Sales Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Maternal and Child Health Service
10.10.3 Laboratory
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thromboelastography Analyzer Sales Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thromboelastography Analyzer Sales Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thromboelastography Analyzer Sales Market Size Forecast by Type
11.6.1 Single and Double Channel
11.6.2 Four Channels
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thromboelastography Analyzer Sales Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Maternal and Child Health Service
11.10.3 Laboratory
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thromboelastography Analyzer Sales Analysis and Forecast
12.1 Introduction
12.2 Latin America Thromboelastography Analyzer Sales Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thromboelastography Analyzer Sales Market Size Forecast by Type
12.6.1 Single and Double Channel
12.6.2 Four Channels
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thromboelastography Analyzer Sales Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Maternal and Child Health Service
12.10.3 Laboratory
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thromboelastography Analyzer Sales Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thromboelastography Analyzer Sales Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thromboelastography Analyzer Sales Market Size Forecast by Type
13.6.1 Single and Double Channel
13.6.2 Four Channels
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thromboelastography Analyzer Sales Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Maternal and Child Health Service
13.10.3 Laboratory
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thromboelastography Analyzer Sales Market: Competitive Dashboard
14.2 Global Thromboelastography Analyzer Sales Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Lepu Technology
14.3.3 Biomart
14.3.4 Medcaptain
14.3.5 Ud-bio
14.3.6 Chongqing Nanfang
14.3.7 WITEYE
14.3.8 Render
14.3.9 Guizhou Jinjiu Biotech
14.3.10 Chongqing Dingrun
14.3.11 Zhejiang Shengyu
14.3.12 Bio-zircon
14.3.13 WerfenLife
14.3.14 Framar Hemologix srl
14.3.15 Sienco